| 1936 |
Nov. |
Toyama Chemical Co., Ltd., established around the business of Toyama Chemical Research Laboratory |
| 1961 |
Feb. |
Head office relocated from Toyama to Nihonbashi, Tokyo |
| Oct. |
Listed on the second section of the Tokyo Stock Exchange |
| 1970 |
Dec. |
General Research Laboratory completed |
| 1971 |
Aug. |
Factory for the manufacture of injectable products completed |
| 1972 |
Apr. |
Listed on the first section of the Tokyo Stock Exchange |
| Jun. |
First phase of pharmaceutical factory completed |
| 1975 |
May |
No. 2 Research Laboratory completed |
| Aug. |
Second phase of pharmaceutical factory completed |
| 1978 |
Feb. |
Head office relocated from Nihonbashi to Shinjuku, Tokyo |
| 1980 |
Feb. |
PENTCILLIN injection and intramuscular introduced |
| Oct. |
No. 3 Research Laboratory completed |
| 1981 |
Sep. |
ABOVIS capsules introduced |
| Dec. |
CEFOPERAZIN injection and intramuscular introduced |
| 1982 |
Aug. |
BAXO capsules introduced |
| 1985 |
Jun. |
No. 5 Research Laboratory completed |
| Jul. |
TOMIPORAN intravenous introduced |
| 1986 |
Nov. |
BAXO ointment introduced |
| 1987 |
Sep. |
TOMIRON tablet introduced |
| 1988 |
Dec. |
BAXO suppositories introduced |
| 1989 |
Nov. |
No. 1 Research Laboratory completed |
| 1990 |
Apr. |
OZEX tablet introduced |
| Sep. |
TOMIRON fine granules introduced |
| 1992 |
Jun. |
SELECAL tablet introduced |
| 1993 |
Jun. |
SARPUL tablet introduced |
| Sep. |
New York Office opened |
| 1994 |
Jan. |
FLUCAM capsules introduced |
| Nov. |
Sales of consumer healthcare products started |
| 1996 |
Oct. |
London Office opened |
| 1997 |
Oct. |
TOYAMA USA INC. established |
| 1998 |
Oct. |
TOYAMA EUROPE LTD. established |
| Pharmaceutical factory and distribution wing completed |
| 1999 |
Feb. |
JAPAN TISSUE ENGINEERING CO., LTD. established |
| Dec. |
LUPRAC tablet introduced |
| 2000 |
Sep. |
Toyama Works and the 2nd Toyama Factory acquired ISO 14001 certification |
| 2001 |
Jun. |
TAZOCIN intravenous introduced |
| 2002 |
Apr. |
HALOSPOR intravenous introduced |
| Aug. |
Agreed on a strategic capital and business alliance with Taisho Pharmaceutical Co., Ltd. |
| Sep. |
PASIL intravenous drip introduced |
| Oct. |
Taisho Toyama Pharmaceutical Co., Ltd. established |
| 2003 |
Feb. |
PENTCILLIN intravenous bag introduced |
| Transferred OTC business to Taisho Pharmaceutical and Kyorin Pharmaceutical Co., Ltd. |
| 2006 |
May |
OZEX ophthalmic solution introduced |
| Oct. |
The entire company acquired ISO 14001 certification |
| Nov. |
No. 6 Research Laboratory completed |
| 2007 |
Oct. |
GENINAX tablet introduced |
| 2008 |
Feb. |
Agreed on a strategic capital and business alliance between FUJIFILM Holdings Corporation, Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. |
| Aug. |
Delisted on the first section of the Tokyo Stock Exchange |
| Oct. |
ZOSYN intravenous introduced |
| 2010 |
Jan. |
OZEX fine granules introduced |
